N4 Pharma (LON:N4P) Trading 23.8% Higher – Should You Buy?

Shares of N4 Pharma Plc (LON:N4P) were up 23.8% during trading on Wednesday . The company traded as high as GBX 0.75 ($0.01) and last traded at GBX 0.65 ($0.01). Approximately 10,628,002 shares traded hands during trading, an increase of 331% from the average daily volume of 2,466,094 shares. The stock had previously closed at GBX 0.53 ($0.01).

N4 Pharma Stock Performance

The stock has a market cap of £2.57 million, a price-to-earnings ratio of -55.00 and a beta of -0.37. The company’s fifty day simple moving average is GBX 0.62 and its two-hundred day simple moving average is GBX 0.57. The company has a debt-to-equity ratio of 1.62, a current ratio of 22.73 and a quick ratio of 7.28.

N4 Pharma Company Profile

N4 Pharma is a specialist pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines It has a unique silica nanoparticle delivery system called Nuvec® and another unique peptide.lipid system called Liptide® which it operates through its subsidiary Nanogenics Ltd

N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.